Nephrolithiasis Associated with Normocalcemic or Hypercalcemic Primary Hyperparathyroidism: An Update on Medical Management

Journal Title: Archives of Renal Diseases and Management - Year 2016, Vol 2, Issue 1

Abstract

Primary hyperparathyroidism (PHPT) is a disease involving a broad range of alterations of calcium homeostasis, sustained by parathyroid hormone (PTH) levels that are clearly abnormal. The anomalies directly associated with hyperparathyroidism are nephrolithiasis and fibrocystic bone disease. Since PHPT resolves when abnormal parathyroid tissue is removed, surgery is clearly the only definitive approach to this type of hyperparathyroidism. However there are large subgroups of patients for whom medical therapy should be considered instead of surgery. Pharmacological therapy consists largely of biphosphonates, or calciomimetics such as cinacalcet. Recent preliminary data suggests however that cinacalcet could also be effective in the specific group of patients with primary hyperparathyroidism associated with nephrolithiasis. Finally, since cinacalcet reduces calcemia in most PHPT patients without improving bone mass, whereas biphosphonates and especially alendronate improve bone mass, it could make sense to combine the two drugs in PHPT patients with concomitant bone loss and possibly nephrolithiasis who cannot or do not wish to undergo surgery.

Authors and Affiliations

Brardi Simone, Duranti Ennio

Keywords

Related Articles

Nephrolithiasis in hypercalcemic and normocalcemic primary Hyperparathyroidism

Primary hyperparathyroidism (PHPT) is a common condition affecting up to 4 per 1000 of population, and the majority of cases are due to adenoma or hyperplasia of the gland [1]. This endocrine disorder may either develop...

Massive Carbon Dioxide Embolism during Pneumoperitoneum for Laparoscopic Adrenalectomy

A 65-year-old man, with suspected right adrenal metastasis from hepatic carcinoma, was scheduled to undergo a laparoscopic right adrenalectomy. About 75 minutes into the operation, when attempting to remove the adrenal g...

Effectiveness and Tolerability of Febuxostat vs Allopurinol in patients with Chronic Kidney Disease (CKD) on Conservative Therapy

Uric Acid appears to be one of the most important prognostic markers and one of the principal risk factors for cardiovascular diseases. The aim of our study was to assess three groups of patients: a first group treated w...

Hemodialysis with Polymethylmethacrylate Restores the Response to Hepatitis B Vaccination in Chronic Dialysis Patients: Hypothesized Mechanism of Action

Patients undergoing hemodialysis often present with a reduced response to anti-hepatitis B virus (anti-HBV) vaccination. The soluble form of CD40 (sCD40) is elevated in hemodialysis patients and this has been shown to co...

Membranoproliferative Glomerulonephritis Preceding Non-Hodgkin Lymphoma Recurrence: A Case Report

Introduction: Membranoproliferative glomerulonephritis has been reported to occur in association with non-Hodgkin’s lymphoma but there is few information about glomerulonephritis response to the treatment of non-Hodgkin’...

Download PDF file
  • EP ID EP343405
  • DOI 10.17352/2455-5495.000010
  • Views 75
  • Downloads 0

How To Cite

Brardi Simone, Duranti Ennio (2016). Nephrolithiasis Associated with Normocalcemic or Hypercalcemic Primary Hyperparathyroidism: An Update on Medical Management. Archives of Renal Diseases and Management, 2(1), 13-18. https://europub.co.uk/articles/-A-343405